Latest Stories
Nicolet Bankshares (NIC): Buy, Sell, or Hold Post Q3 Earnings?
Nicolet Bankshares currently trades at $122.16 per share and has shown little upside over the past six months, posting a small loss of 1.1%. The stock also fell short of the S&P 500’s 11.3% gain during that period.
3 Reasons to Avoid REGN and 1 Stock to Buy Instead
What a fantastic six months it’s been for Regeneron. Shares of the company have skyrocketed 47.6%, hitting $774.98. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons FORM is Risky and 1 Stock to Buy Instead
What a fantastic six months it’s been for FormFactor. Shares of the company have skyrocketed 66%, hitting $57.11. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons BA is Risky and 1 Stock to Buy Instead
Since July 2025, Boeing has been in a holding pattern, posting a small return of 4.4% while floating around $218.84. The stock also fell short of the S&P 500’s 11.3% gain during that period.
3 Reasons to Sell FFIV and 1 Stock to Buy Instead
Over the last six months, F5’s shares have sunk to $258.88, producing a disappointing 12% loss - a stark contrast to the S&P 500’s 11.3% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
2 Reasons to Avoid AFRM and 1 Stock to Buy Instead
Affirm has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.8% to $75.95 per share while the index has gained 11.3%.
2 Reasons to Like LDOS (and 1 Not So Much)
Leidos trades at $183.35 and has moved in lockstep with the market. Its shares have returned 16.2% over the last six months while the S&P 500 has gained 11.3%.
3 Reasons BAND is Risky and 1 Stock to Buy Instead
Since July 2025, Bandwidth has been in a holding pattern, floating around $15.84. The stock also fell short of the S&P 500’s 11.3% gain during that period.
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings?
AbbVie has had an impressive run over the past six months as its shares have beaten the S&P 500 by 12.4%. The stock now trades at $229.70, marking a 23.7% gain. This performance may have investors wondering how to approach the situation.
3 Reasons to Sell KE and 1 Stock to Buy Instead
The past six months have been a windfall for Kimball Electronics’s shareholders. The company’s stock price has jumped 48.6%, hitting $28.59 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.